-transparent.png){kind=logo}
Inflammatory bowel diseases (IBDs), divided into two predominant groups, Crohn's disease (CD) and ulcerative colitis (UC), are chronic relapsing inflammatory diseases of the gastrointestinal tract, resulting from an aberrant immune response to microbes in the gut, in genetically susceptible patients [...].
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
July 1998,
Expert opinion on investigational drugs,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
November 2003,
Nursing,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
June 2009,
Rinsho byori. The Japanese journal of clinical pathology,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
June 1999,
Gastroenterology clinics of North America,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
February 2017,
Trends in pharmacological sciences,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
June 2006,
Current treatment options in gastroenterology,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
February 1995,
European journal of gastroenterology & hepatology,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
January 2013,
Digestive diseases (Basel, Switzerland),
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
January 2021,
Frontiers in pharmacology,
Federica Furfaro, and
Elisa Ragaini, and
Laurent Peyrin-Biroulet, and
Silvio Danese
March 2023,
Inflammatory bowel diseases,
